文献速递炎症性肠病

炎症性肠病患者的造口周围坏疽性脓皮病:危险因素与治疗结局

Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2020-05-07

这项回顾性队列研究在三级中心纳入41例合并造口周围坏疽性脓皮病(PPG)的炎症性肠病(IBD)患者和123例从未发生PPG的造口IBD对照,比较两组特征并评估PPG治疗反应。结果显示女性、较高BMI和使用造口袋腰带与PPG风险增加相关,85%的PPG患者经不同治疗(包括手术)达到完全缓解,抗TNF药物和手术的完全缓解率较高。

要点

  • 女性、较高BMI和使用造口袋腰带与IBD患者发生PPG风险增加相关。
  • 85%的PPG患者经不同治疗达到完全缓解,包括手术。
  • 单用局部糖皮质激素或钙调神经磷酸酶抑制剂的完全缓解率较低。

核心结论

  • 女性、较高BMI和使用造口袋腰带与IBD患者发生PPG风险增加相关。
  • 大多数PPG病例经治疗后可缓解,抗TNF药物和手术干预的完全缓解率最高。

研究设计与样本

  • 回顾性队列研究,使用ICD-9/10编码在三级中心识别有造口的IBD患者中的PPG病例。
  • 纳入41例IBD合并PPG患者和123例从未发生PPG的造口IBD对照。
  • 比较两组疾病特异性特征,并评估PPG患者的治疗反应。

主要发现

  • PPG患者女性比例高于对照(76% vs 51%,P = 0.006)。
  • PPG患者BMI高于对照(29.78 ± 0.89 vs 23.53 ± 0.51,P < 0.0001)。
  • PPG患者使用造口袋腰带比例高于对照(97% vs 71%,P = 0.0008)。
  • 两组手术时年龄(41.76 ± 2.60 vs 43.49 ± 1.50,P = 0.57)和IBD诊断(克罗恩病63% vs 54%,P = 0.28)无差异。
  • 85%的PPG患者经不同治疗(包括手术)达到完全缓解;单用局部糖皮质激素和钙调神经磷酸酶抑制剂的完全缓解率分别为14%和13%,抗TNF药物为63%,手术干预为80%。

临床怎么用

  • 对造口IBD患者应关注女性、较高BMI和使用造口袋腰带等PPG风险因素。
  • PPG治疗可考虑抗TNF药物或手术干预以提高完全缓解率。
  • 单用局部糖皮质激素或钙调神经磷酸酶抑制剂完全缓解率较低,需综合治疗策略。

局限性

  • 回顾性研究设计。
  • 单中心三级中心数据。
  • 样本量有限(41例PPG患者)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Insufficient data exist for peristomal pyoderma gangrenosum (PPG), which primarily affects patients with inflammatory bowel disease (IBD). AIMS: To evaluate the risk factors and treatment response of PPG in IBD patients in a real-life cohort. METHODS: Cases of PPG were identified retrospectively using ICD-9/10 codes in patients with IBD who had an ostomy at a tertiary care centre. Disease-specific characteristics were compared between groups with and without PPG, and response to therapy was evaluated in patients with PPG. RESULTS: The cohort included 41 IBD patients with PPG and 123 IBD controls with an ostomy who never developed PPG. Patients with PPG were more likely to be female (76% vs 51%, P = 0.006), had higher BMIs (29.78 ± 0.89 vs 23.53 ± 0.51, P < 0.0001) and had increased usage of pouch belts (97% vs 71%, P = 0.0008) compared to controls. There were no differences in age at surgery (41.76 ± 2.60 vs 43.49 ± 1.50, P = 0.57) or IBD diagnosis (63% vs 54% Crohn's disease, P = 0.28) between PPG and controls. 85% of PPG patients achieved complete resolution with different treatments, including surgery. Complete resolution with topical corticosteroids and calcineurin inhibitors alone were low (14% and 13% respectively). Higher rates of complete resolution were reported with anti-tumour necrosis factor (TNF) agents (63%) and surgical interventions (80%). CONCLUSIONS: Female gender, higher BMI and pouch belts were associated with increased risk of developing PPG. Most PPG cases resolved after treatment with the highest rates of complete resolution seen with anti-TNF agents and surgical intervention.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Wang J, Prenner J, Wang W, et al. Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020. PMID: 32383278. doi:10.1111/apt.15766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。